Total synthesis of (-)-reveromycin B

Organic Letters

Volumn 2, Issue 2, 2000, Pages 191-194

  Cuzzupe, Anthony N ^a   Hutton, Craig A ^a   Lilly, Michael J ^a   Mann, Robert K ^a   Rizzacasa, Mark A ^a   Zammit, Steven C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR; PYRAN DERIVATIVE; REVEROMYCIN B; SPIRO COMPOUND;

ARTICLE; DRUG ANTAGONISM; STEREOISOMERISM; SYNTHESIS;

ANTINEOPLASTIC AGENTS; EPIDERMAL GROWTH FACTOR; PYRANS; SPIRO COMPOUNDS; STEREOISOMERISM;

EID: 0034719246     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol991281m     Document Type: Article

References (30)

1. Takahashi, H.; Osada, H.; Koshino, H.; Kudo, T.; Amano, S.; Shimizu, S.; Yoshihama, M.; Isono, K. J. Antibiot. 1992, 45, 1409-1413.
2. Koshino, H.; Takahashi, H.; Osada, H.; Isono, K. J. Antibiot. 1992, 45, 1420-1427.
3. Takahashi, H.; Osada, H.; Koshino, H.; Sasaki, M.; Onose, R.; Nakakoshi, M.; Yoshihama, M.; Isono, K. J. Antibiot. 1992, 45, 1414-1419.
4. Ubukata, M.; Kishino, H.; Osada, H.; Isono, K. J. Chem. Soc., Chem. Commun. 1994, 1877-1878.
5. Shimizu, T.; Kobayashi, R.; Osako, K.; Osado, H.; Nakata, T. Tetrahedron Lett. 1996, 37, 6755-6758.
6. McRae, K. J.; Rizzacasa, M. A. J. Org. Chem. 1997, 62, 1196-1197.
7. Drouet, K. E.; Theodorakis, E. A. J. Am. Chem. Soc. 1999, 121, 456-457.
8. Masuda, T.; Osako, K.; Shimizu, T.; Nakata, T. Org. Lett. 1999, 1, 941-944.
9. (a) Paul, R.; Tchelitcheff, S. Bull. Soc. Chim. Fr. 1954, 672-678.
10. (b) Ireland, R. E.; Häbich, D. Chem. Ber. 1981, 114, 1418-1427.
11. (c) Sauvé, G.; Schwartz, D. A.; Ruest, L.; Deslongchamps, P. Can. J. Chem. 1984, 62, 2929-2935.
12. (d) Tietze, L. F.; Schneider, C. J. Org. Chem. 1991, 54, 2476-2481.
13. Murray, R. W.; Jeyaraman, R. J. J. Org. Chem. 1985, 50, 2847-2853.
14. (a) Buchta, E.; Andrée, F. Chem. Ber. 1959, 92, 3111-3116.
15. (b) Le Corre, M. Tetrahedron Lett. 1974, 1037-1040. We found that the conjugated ylide i reported by Buchta reacted with aliphatic aldehydes such as hexanal to give an undesired isomeric diene ii as the major product: matrix presented
16. Dess, D. B.; Martin, J. C. J. Am. Chem. Soc. 1991, 113, 7277-7287. Unbuffered Dess-Martin oxidation resulted in formation of a small amount of another aldehyde tenatively assigned as the C8-C9 geometric isomer of 12.
17. (a) Nagao, Y.; Hagiwara, Y.; Kumagi, T.; Ochiai, M.; Inoue, T.; Hashimoto, K.; Fujita, E. J. Org. Chem. 1986, 51, 2391-2393.
18. (b) Nagao, Y.; Yamada, S.; Kumagai, T.; Ochiai, M.; Fujita, E. J. Chem. Soc., Chem. Commun. 1985, 1418-1419.
19. (c) Nagao, Y.; Kumagai, T.; Yamada, S.; Fujita, E.; Inoue, Y.; Nagase, Y.; Aoyagi, S.; Abe, T. J. Chem. Soc., Perkin Trans. 1 1985, 2361-2367.
20. Details of this study will appear in a full account of this work.
21. (a) Stille, J. K. Angew. Chem., Int. Ed. Engl. 1986, 25, 508-524.
22. (b) Farina, V.; Krishnamurthy V. Scott W. J. In Organic Reactions; Paquette, L. A., Ed.; J. Wiley and Sons: New York, 1997; pp 1-652.
23. Zhang, H. X.; Guibé, F.; Balavoine, G. J. Org. Chem. 1990, 55, 1857-1867.
24. 2) of the known acid: LeNoble, W. J. J. Am. Chem. Soc. 1961, 83, 3897-3899.
25. Farina, V.; Krishnan, B. J. Am. Chem. Soc. 1991, 113, 9585-9595.
26. 3, DMAP, and N-hydroxysuccinimide: Guzzo, P. R.; Miller, M. J. J. Org. Chem. 1994, 59, 4862-4867.
27. The Tmse esters were stable to these conditions. A Tmse phosphonate ester has been shown to be stable to HF·pyridine/pyridine; see: Evans, D. A.; Gage, J. R.; Leighton, J. L. J. Am. Chem. Soc. 1992, 114, 9434-9453.
28. Tmse ylide preparation: Hungerbühler, E.; Seebach, D.; Wasmuth, D. Helv. Chim. Acta 1981, 64, 1467-1487.
29. Sieber, P. Helv. Chim. Acta 1977, 60, 2711-2716. When TBAF in THF was utilized for the deprotection, the Tmse groups were removed rapidly but some C5 OTBS reveromycin B remained even after prolonged exposure. Deprotection was more effective with TBAF in DMF.
30. We thank Dr. Hidetoshi Takahashi (Research Institute of Life Science, Snow Brand Milk Products Co. Ltd., Japan) for copies of the NMR spectra of reveromycin B.